BIOSPECIFICS TECHNOLOGIES CORP Capitalized Contract Cost, Amortization
BIOSPECIFICS TECHNOLOGIES CORP reported Capitalized Contract Cost, Amortization of $200.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedContractCostAmortization · last filed 2020-08-10
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for the quarter ending 2019-03-31 was $200.00K, a 60.00% decline year-over-year.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for fiscal 2019 was $200.00K, a 90.00% decline from fiscal 2018.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for fiscal 2018 was $2.00M, a 33.33% increase from fiscal 2017.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for fiscal 2017 was $1.50M, a 50.00% increase from fiscal 2016.
- BIOSPECIFICS TECHNOLOGIES CORP capitalized contract cost, amortization for fiscal 2016 was $1.00M.
| Period end | Capitalized Contract Cost, Amortization 3 month | Capitalized Contract Cost, Amortization 6 month | Capitalized Contract Cost, Amortization 9 month | Capitalized Contract Cost, Amortization 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $0.00 derived: sum of 3 quarters · filed 2020-08-10 | $200.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-08-10 | $200.00K 10-Q · filed 2019-11-12 | $600.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $200.00K 10-Q · filed 2020-08-10 | $600.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.20M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-11 | $600.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.20M derived: sum of 3 quarters · filed 2020-05-11 | $1.70M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.00M derived: sum of 2 quarters · filed 2020-03-16 | $1.50M derived: sum of 3 quarters · filed 2020-03-16 | $2.00M 10-K · filed 2020-03-16 |
| 2018-09-30 | $600.00K 10-Q · filed 2019-11-12 | $1.10M derived: sum of 2 quarters · filed 2019-11-12 | $1.60M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $500.00K 10-Q · filed 2019-08-09 | $1.00M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $500.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $1.50M 10-K · filed 2019-04-02 | |||
| 2016-12-31 | $1.00M 10-K · filed 2019-04-02 |